At the end of this activity learners should be able to: 1) Explain how to select appropriate molecular tests and interpret the results; 2) Recognize diagnostically relevant molecular biomarkers; 3) Describe clinico-pathological scenarios that require molecular biomarker testing; 4) Explain how to interpret molecular test results and generate integrated histo-molecular diagnosis for CNS tumors; 5) Discuss technical aspects of various molecular testing platforms including next-generation sequencing, genome-wide chromosomal microarrays and global methylation analysis.
- Provider:American Association of Neuropathologists
- Activity Link: https://aanp.memberclicks.net/molecularneuropath
- Start Date: 2024-08-12 05:00:00
- End Date: 2024-08-12 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 10.0 hours
- MOC Credit Details: ABPATH - 10.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
- Commercial Support: Source: Chimerix, Inc. - Amount: 26025.0 - Is Kind Support: False
- Activity Type: Regularly Scheduled Series
- CME Finder Type: In-House Seminar
- Fee to Participate: Variable
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Molecular Genetic Pathology, Neuropathology (incl. Neuromuscular)
Subscribe
Login
0 Comments
Oldest